Form 4: SANUWAVE Health Insider Filing: Manchester Explorer, L.P. Reports Transactions Following Reverse Stock Split
SEC Form 4 Filing
Manchester Explorer, L.P. and related parties report transactions involving warrants and convertible notes of SANUWAVE Health, Inc. following a 1-for-375 reverse stock split.
Summary
- This Form 4 filing details changes in beneficial ownership of SANUWAVE Health, Inc. [SNWV] securities by Manchester Explorer, L.P. and related parties.
- The filing reflects transactions following a 1-for-375 reverse stock split that was implemented on October 18, 2024.
- The reported transactions involve Future Advance Convertible Promissory Notes and Common Stock Purchase Warrants.
- The warrants are being exchanged for warrants with different terms, as per a letter agreement between the reporting persons and the issuer.
- The reported securities are owned directly by Manchester Explorer, L.P. and may be deemed to be indirectly beneficially owned by Manchester Management Company, LLC, Manchester Management PR, LLC, James E. Besser, and Morgan Frank.
- The exercise of the notes and warrants is subject to limitations, including the availability of authorized and unissued shares.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, so the sentiment is neutral.
Risks
- The exercise of the reported warrants and convertible notes is subject to limitations and conditions, including the availability of sufficient authorized and unissued shares, which could impact the potential value of these securities.
- The value of the warrants and convertible notes is dependent on SANUWAVE Health, Inc.'s stock price and its ability to meet the conditions for exercise.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into insider transactions, ensuring fair markets and preventing information asymmetry.
Stakeholder Impact
- Shareholders are informed about the transactions of significant shareholders and related parties.
- The reverse stock split impacts the number of shares held by all shareholders.
Key Dates
| Date | Description |
|---|---|
| 12/31/2022 | Reference to Issuer's Annual Report on Form 10-K for the year ended December 31, 2022. |
| 07/21/2023 | Date of the letter agreement between the Issuer and the lenders of the Asset-Backed Secured Promissory Notes (July 2023 Notes). |
| 07/26/2023 | Reference to the Schedule 13D filed by the Reporting Persons. |
| 09/29/2023 | Reference to the Issuer's S-1/A filing. |
| 12/31/2023 | Date related to Future Advance Convertible Promissory Note. |
| 01/21/2024 | Maturity Date of the Future Advance Convertible Promissory Note. |
| 10/15/2024 | Issuer filed a Certificate of Amendment to implement a 1-for-375 reverse stock split. |
| 10/18/2024 | Effective date of the 1-for-375 reverse stock split. |
| 10/18/2024 | Transaction date for warrant exchanges. |
| 10/23/2024 | Date of the Form 4 filing. |
| 12/30/2028 | Expiration date of Common Stock Purchase Warrants. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.